Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dersalazine in mild to moderate active ulcerative colitis
NCT00808977Phase 2Completed
- Sponsor
- Palau Pharma
- Start
- Dec 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of dersalazine sodium in ulcerative colitis (UC), sponsored by Palau Pharma. Started Dec 2008; status: completed.
02
Drugs
dersalazine sodium
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00808977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808977.